Access Bio Inc (950130) - Total Liabilities

Latest as of June 2025: ₩67.08 Billion KRW ≈ $45.46 Million USD

Based on the latest financial reports, Access Bio Inc (950130) has total liabilities worth ₩67.08 Billion KRW (≈ $45.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Access Bio Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Access Bio Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Access Bio Inc to evaluate short-term liquidity relative to the company's equity base.

Access Bio Inc Competitors by Total Liabilities

The table below lists competitors of Access Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Avaco Co. Ltd KQ:083930	Korea	₩101.68 Billion
China National Accord Medicines Corp Ltd SHE:200028	China	HK$27.21 Billion
Spring Valley Acquisition Corp. II Class A Ordinary Shares NASDAQ:SVII	USA	$5.87 Million
K2 Gold Corporation V:KTO	Canada	CA$831.95K
Caisse Régionale du Crédit Agricole Alpes Provence PA:CRAP	France	€23.14 Billion
Igis Value Plus Reit Co Ltd KO:334890	Korea	₩106.26 Billion
Business Online PCL BK:BOL	Thailand	฿453.29 Million
Arihant Superstructures Limited NSE:ARIHANTSUP	India	Rs13.20 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Access Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 950130 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Access Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Access Bio Inc (2012–2024)

The table below shows the annual total liabilities of Access Bio Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩61.70 Million ≈ $41.81K	-99.94%
2023-12-31	₩104.00 Billion ≈ $70.48 Million	+49192.84%
2022-12-31	₩210.97 Million ≈ $142.97K	+60.93%
2021-12-31	₩131.10 Million ≈ $88.84K	+64.97%
2020-12-31	₩79.47 Million ≈ $53.86K	+103.73%
2019-12-31	₩39.01 Million ≈ $26.43K	-24.11%
2018-12-31	₩51.40 Million ≈ $34.83K	+11.67%
2017-12-31	₩46.03 Million ≈ $31.19K	+5.38%
2016-12-31	₩43.68 Million ≈ $29.60K	-98.97%
2015-12-31	₩4.24 Billion ≈ $2.87 Million	-59.04%
2014-12-31	₩10.35 Billion ≈ $7.01 Million	+15.08%
2013-12-31	₩8.99 Billion ≈ $6.09 Million	+21.79%
2012-12-31	₩7.38 Billion ≈ $5.00 Million	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$125.38 Million

₩185.01 Billion KRW

Market Cap Rank

#18422 Global

#836 in Korea

Share Price

₩5260.00

Change (1 day)

-1.31%

52-Week Range

₩5140.00 - ₩5690.00

All Time High

₩29950.00